Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients

被引:53
作者
Almeida, Sandra [1 ]
Sarmento-Ribeiro, Ana Bela [1 ,2 ,3 ]
Januario, Cristina
Rego, A. Cristina [1 ,2 ]
Oliveira, Catarina R. [1 ,2 ,4 ]
机构
[1] Univ Coimbra, Ctr Neurosci & Cell Biol Coimbra, P-3004504 Coimbra, Portugal
[2] Univ Coimbra, Fac Med, Inst Biochem, P-3004504 Coimbra, Portugal
[3] Univ Coimbra, Fac Med, Ctr Invest Environm Genet & Oncobiol CIMAGO, P-3004504 Coimbra, Portugal
[4] Univ Coimbra, Univ Hosp, Neurol Unit, P-3004504 Coimbra, Portugal
关键词
Huntington's disease; Bax; mitochondrial dysfunction; apoptosis; lymphocytes; neutrophils; monocytes;
D O I
10.1016/j.bbrc.2008.07.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms by which neurons die in Huntington's disease (HD) are uncertain, however, mitochondrial dysfunction and apoptosis have been implicated. Because peripheral abnormalities may reflect similar consequences of mutant huntingtin in the brain, we evaluated markers of apoptotic cell death and mitochondrial function in peripheral blood cells of 10 HD patients and 16 age- and gender-matched controls. We found increased Bax expression in B and T lymphocytes, and monocytes from HD patients, but no alterations in Bcl-2 expression levels. B lymphocytes also showed decreased mitochondrial membrane potential. However, HD peripheral blood cells showed no differences in reactive oxygen species (ROS) levels when compared to controls. Our results suggest that peripheral blood cells, in particularly B lymphocytes may reflect changes observed in HD brain. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:599 / 603
页数:5
相关论文
共 32 条
[1]   p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease [J].
Bae, BI ;
Xu, H ;
Igarashi, S ;
Fujimuro, M ;
Agrawal, N ;
Taya, Y ;
Hayward, SD ;
Moran, TH ;
Montell, C ;
Ross, CA ;
Snyder, SH ;
Sawa, A .
NEURON, 2005, 47 (01) :29-41
[2]   Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin [J].
Benchoua, A ;
Trioulier, Y ;
Zala, D ;
Gaillard, MC ;
Lefort, N ;
Dufour, N ;
Saudou, F ;
Elalouf, JM ;
Hirsch, E ;
Hantraye, P ;
Déglon, N ;
Brouillet, E .
MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (04) :1652-1663
[3]   Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease [J].
Borovecki, F ;
Lovrecic, L ;
Zhou, J ;
Jeong, H ;
Then, F ;
Rosas, HD ;
Hersch, SM ;
Hogarth, P ;
Bouzou, B ;
Jensen, RV ;
Krainc, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (31) :11023-11028
[4]   Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia [J].
Browne, SE ;
Bowling, AC ;
MacGarvey, U ;
Baik, MJ ;
Berger, SC ;
Muqit, MMK ;
Bird, ED ;
Beal, MF .
ANNALS OF NEUROLOGY, 1997, 41 (05) :646-653
[5]  
Browne SE, 1999, BRAIN PATHOL, V9, P147
[6]   Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients [J].
Chen, Chiung-Mei ;
Wu, Yih-Ru ;
Cheng, Mei-Ling ;
Liu, Jun-Liang ;
Lee, Yu-May ;
Lee, Po-Wei ;
Soong, Bing-Wen ;
Chiu, Daniel Tsun-Yee .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 359 (02) :335-340
[7]   Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release [J].
Choo, YS ;
Johnson, GVW ;
MacDonald, M ;
Detloff, PJ ;
Lesort, M .
HUMAN MOLECULAR GENETICS, 2004, 13 (14) :1407-1420
[8]   Akt is altered in an animal model of Huntington's disease and in patients [J].
Colin, E ;
Régulier, E ;
Perrin, V ;
Dürr, A ;
Brice, A ;
Aebischer, P ;
Déglon, N ;
Humbert, S ;
Saudou, F .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2005, 21 (06) :1478-1488
[9]   Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome [J].
Cossarizza, A ;
Mussini, C ;
Mongiardo, N ;
Borghi, V ;
Sabbatini, A ;
DeRienzo, B ;
Franceschi, C .
AIDS, 1997, 11 (01) :19-26
[10]   Fas and Fas-L expression in Huntington's disease and Parkinson's disease [J].
Ferrer, I ;
Blanco, R ;
Cutillas, B ;
Ambrosio, S .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2000, 26 (05) :424-433